biote Corp. – NASDAQ:BTMD
biote Corp. stock price today
$3.02
-2.97
-49.58%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 3 days
biote Corp. stock price monthly change
-26.05%
month
biote Corp. stock price quarterly change
-26.05%
quarter
biote Corp. stock price yearly change
+19.09%
year
biote Corp. key metrics
Market Cap | 322.76M |
Enterprise value | N/A |
P/E | -47.75 |
EV/Sales | -0.10 |
EV/EBITDA | -0.18 |
Price/Sales | 0.19 |
Price/Book | -0.79 |
PEG ratio | 0.46 |
EPS | 0.17 |
Revenue | 187.32M |
EBITDA | 39.86M |
Income | 8.05M |
Revenue Q/Q | 4.37% |
Revenue Y/Y | 8.49% |
Profit margin | 50.86% |
Oper. margin | -56.78% |
Gross margin | 68.06% |
EBIT margin | -56.78% |
EBITDA margin | 21.28% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freebiote Corp. stock price history
biote Corp. stock forecast
biote Corp. financial statements
| Jun 2023 | 49.25M | -5.14M | -10.44% |
|---|---|---|---|
| Sep 2023 | 45.55M | 7.53M | 16.53% |
| Dec 2023 | 45.70M | 7.73M | 16.92% |
| Mar 2024 | 46.80M | -2.06M | -4.42% |
| Sep 2025 | 61.68M | 3.80M | 6.16% |
|---|---|---|---|
| Oct 2025 | 59.76M | 6.23M | 10.43% |
| Dec 2025 | 65.38M | 8.13M | 12.44% |
| Mar 2026 | 67.47M | 0 |
Analysts Price target
Financials & Ratios estimates
| 2023-11-07 | 0.08 | -0.11 |
|---|---|---|
| 2024-03-12 | 0.08 | 0.18 |
| 2024-05-07 | 0.05 | 0.23 |
0%
Yield TTM
| Payout ratio | 0% |
|---|
| 2019 | 74.4% |
|---|---|
| 2020 | 17.5% |
| 2021 | 15.36% |
| 2022 | 42.87% |
| 2023 | 6.85% |
| Jun 2023 | 139052000 | 212.29M | 152.67% |
|---|---|---|---|
| Sep 2023 | 149749000 | 201.01M | 134.23% |
| Dec 2023 | 155295000 | 191.84M | 123.53% |
| Mar 2024 | 160108000 | 205.00M | 128.04% |
| Jun 2023 | 6.77M | -20.84M | -5.05M |
|---|---|---|---|
| Sep 2023 | 160K | -484K | -2.56M |
| Dec 2023 | 6.95M | 18.99M | -2.52M |
| Mar 2024 | 7.37M | -12.17M | -5.40M |
biote Corp. alternative data
| Aug 2023 | 186 |
|---|---|
| Sep 2023 | 186 |
| Oct 2023 | 186 |
| Nov 2023 | 186 |
| Dec 2023 | 186 |
| Jan 2024 | 186 |
| Feb 2024 | 186 |
| Mar 2024 | 194 |
| Apr 2024 | 194 |
| May 2024 | 194 |
| Jun 2024 | 194 |
| Jul 2024 | 194 |
biote Corp. other data
35.61%
+18.77%
of BTMD is owned by hedge funds
2.86M
+1.58M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jul 2024 | 0 | 11376 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | PETERSON ROBERT CHARLES officer: Chief Financial Officer | Class A Common Stock | 11,376 | $7.57 | $86,082 | ||
Option | PETERSON ROBERT CHARLES officer: Chief Financial Officer | Class A Common Stock | 44,250 | N/A | N/A | ||
Option | PETERSON ROBERT CHARLES officer: Chief Financial Officer | Restricted Stock Unit | 44,250 | N/A | N/A | ||
Option | JACOBY DANA LYNN director | Class A Common Stock | 11,595 | N/A | N/A | ||
Option | MORRIS DEBRA L director | Class A Common Stock | 9,110 | N/A | N/A | ||
Option | MORRIS DEBRA L director | Deferred Settlement RSU | 9,110 | N/A | N/A | ||
Option | JACOBY DANA LYNN director | Deferred Settlement RSU | 11,595 | N/A | N/A | ||
Sale | CONLON MARY ELIZABETH officer: General Counsel | Class A Common Stock | 12,480 | $6.5 | $81,145 | ||
Option | CONLON MARY ELIZABETH officer: General Counsel | Class A Common Stock | 48,462 | N/A | N/A | ||
Option | CONLON MARY ELIZABETH officer: General Counsel | Phantom Stock | 48,462 | N/A | N/A |
| Quarter | Transcript |
|---|---|
| Q4 2023 12 Mar 2024 | Q4 2023 Earnings Call Transcript |
-
What's the price of biote Corp. stock today?
One share of biote Corp. stock can currently be purchased for approximately $3.02.
-
When is biote Corp.'s next earnings date?
Unfortunately, biote Corp.'s (BTMD) next earnings date is currently unknown.
-
Does biote Corp. pay dividends?
No, biote Corp. does not pay dividends.
-
How much money does biote Corp. make?
biote Corp. has a market capitalization of 322.76M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 12.37% to 185.36M US dollars. biote Corp. earned 3.32M US dollars in net income (profit) last year or $0.23 on an earnings per share basis.
-
What is biote Corp.'s stock symbol?
biote Corp. is traded on the NASDAQ under the ticker symbol "BTMD".
-
What is biote Corp.'s primary industry?
Company operates in the Healthcare sector and Medical - Care Facilities industry.
-
How do i buy shares of biote Corp.?
Shares of biote Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does biote Corp. have?
As Jul 2024, biote Corp. employs 194 workers.
-
When biote Corp. went public?
biote Corp. is publicly traded company for more then 4 years since IPO on 28 Apr 2021.
-
What is biote Corp.'s official website?
The official website for biote Corp. is biote.com.
-
Where are biote Corp.'s headquarters?
biote Corp. is headquartered at 1875 West Walnut Hill Lane, Irving, TX.
-
How can i contact biote Corp.?
biote Corp.'s mailing address is 1875 West Walnut Hill Lane, Irving, TX and company can be reached via phone at +84 46041246.
biote Corp. company profile:
biote Corp.
biote.comExchange:
NASDAQ
Full time employees:
194
Industry:
Medical - Care Facilities
Sector:
Healthcare
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.
1875 West Walnut Hill Lane
Irving, TX 75038
Irving, TX 75038
CIK: 0001819253
ISIN: US0906831039
CUSIP: 090683103
